The conundrum of anti-angiogenesis in cancer
“Anti-angiogenesis in cancer is something of a conundrum where the unexpected is to be expected.”...
Most Read
An interview with Sam Schulman
Sam Schulman Professor, Division of Hematology and Thromboembolism, Department of Medicine, McMaster University,...
Measurement of extracellular vesicles and their role in cancer-associated thrombosis
Extracellular vesicles (EV) are submicron vesicles released from activated cells, apoptotic cells and cancer cells...
PROGRAM NOW AVAILABLE: 12th International Conference on Thrombosis and Hemostasis Issue in Cancer
Program now available for the 12th International Conference on Thrombosis and Hemostasis Issues in Cancer (ICTHIC),...
Incidental VTE: to treat or not to treat? – A debate from the 10th ICTHIC
During the 10th ICTHIC, Prof. Marcello di Nisio (University of Chieti, Italy) and Prof. Marc Carrier (Ottawa Hospital...
Should we test pediatric cancer patients for thrombophilia: YES
Venous thromboembolism (VTE) in children is a rare disease usually as a secondary complication of primary underlying...
Multiple myeloma-associated VTE risk prediction. A talk report from the 10th ICTHIC
During the 10th ICTHIC, prof Kristen Sanfilippo (Assistant Professor at the Washington University School of Medicine in...
Is thrombosis of retinal veins a marker of occult cancer?
Although thrombosis of the retinal veins (either central or branch retinal vein thrombosis) is usually perceived as...
Long-term cancer survivors: a growing population at risk
Continued rapid advancement in cancer treatment and early cancer detection have resulted in a steady growth of the...
PODCAST. Thrombosis and coagulation in the contemporary management of breast cancer. Waiting for ICTHIC 2022
Breast cancer is the most commonly diagnosed cancer in women accounting for a quarter of cancer cases worldwide. This...